PACSIN2

Protein kinase C and casein kinase substrate in neurons protein 2 · Q9UNF0 · PACSIN2 on Sugi Atlas →

0 patent compounds predicted against PACSIN2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PACSIN2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate PHASE2/PHASE3WITHDRAWN
Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19 PHASE2COMPLETED
Doxycycline in Human Pulmonary Tuberculosis PHASE2COMPLETED
Study in Adult Ph-positive ALL PHASE2UNKNOWN
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer PHASE2COMPLETED
Dietary Fish Protein in Subjects With Insulin Resistance PHASE2COMPLETED
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma PHASE1/PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Bioequivalence Study of Tacrolimus in Healthy Volunteers PHASE1COMPLETED
FAK Inhibitor in Patients With Advanced Solid Tumors PHASE1NOT_YET_RECRUITING
Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer PHASE1WITHDRAWN
Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212 EARLY_PHASE1COMPLETED
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer EARLY_PHASE1COMPLETED
Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic Syndrome nanCOMPLETED
Duality of Lipids: the Athlete's Paradox nanCOMPLETED
Ischemic Preconditioning - Perspectives of Use Vivio/in Vitro Studies nanENROLLING_BY_INVITATION
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure nanRECRUITING
Immune Cell Response to Stimuli nanRECRUITING
p-AKT Expression on Clinical Outcomes in Malignant Lymphoma nanCOMPLETED
Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases. nanNOT_YET_RECRUITING
Free Fatty Acid Induced Insulin Resistance nanCOMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Effect of Esterogen Receptor Modulator on Gene in Bipolar Diseas nanNOT_YET_RECRUITING
The Effect of Blueberries on Enhancing Insulin Sensitivity in Humans: A Pilot Study nanWITHDRAWN
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Protein Intake and Step Reduction in Older Adults nanCOMPLETED
JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders nanCOMPLETED
Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PACSIN2 binder may also engage these)

ProteinNameSimilarity
Q9QY17 1.000 Q9QY17 →
Q9DDA9 1.000 Q9DDA9 →
Q9WVE8 1.000 Q9WVE8 →
O13154 1.000 O13154 →
Q5R411 1.000 Q5R411 →
Q9BY11 0.999 Q9BY11 →
A7MBI0 0.999 A7MBI0 →
Q61644 0.998 Q61644 →
Q9Z0W5 0.994 Q9Z0W5 →
Q4V920 0.994 Q4V920 →
Q0JRZ9 0.986 Q0JRZ9 →
Q5R807 0.985 Q5R807 →
Q5U3Q6 0.984 Q5U3Q6 →
Q3UQN2 0.983 Q3UQN2 →
Q9UHR4 0.983 Q9UHR4 →
D3ZYR1 0.982 D3ZYR1 →
Q8CJ53 0.982 Q8CJ53 →
Q3KR97 0.982 Q3KR97 →
O94868 0.981 O94868 →
O35180 0.981 O35180 →
Q3USJ8 0.981 Q3USJ8 →
Q9DBJ3 0.980 Q9DBJ3 →
Q5RCJ1 0.980 Q5RCJ1 →
Q8I190 0.980 Q8I190 →
P97531 0.979 P97531 →
Q99963 0.979 Q99963 →
SNX9 Sorting nexin-9 0.979 landscape →
Q8I1A6 0.979 Q8I1A6 →
O43295 0.978 O43295 →
Q8I1I3 0.978 Q8I1I3 →